EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential Association of Visceral and Subcutaneous Adipose Tissue with Treatment Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Hye Jin Kang iD, Yong Kyun Won iD, Eun Seog Kim, Sang Mi Lee iD, Ik Dong Yoo iD, Jeong Won Lee iD, Sun-Pyo Hong, Moo-Jun Baek, Dong Hyun Kang, Mee-Hye Oh, Ji-Hye Lee, Si-Hyong Jang iD und 5 weitere

Diagnostics · 26.05.2026 · 16 (11) · 1624

DOI: 10.3390/diagnostics16111624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 26.05.2026. Verfasst von Hye Jin Kang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Soonchunhyang University Hospital Cheonan, Soonchunhyang University Research Fund, Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In locally advanced rectal cancer, neoadjuvant concurrent chemoradiotherapy (CCRT) followed by surgery is the standard treatment. Pathologic complete response (pCR) is strongly associated with favorable long-term outcomes; however, reliable pre-treatment biomarkers for predicting treatment response remain limited. This study aimed to investigate the association between CT-derived adipose tissue parameters and pathologic response following neoadjuvant CCRT.

Methods

A total of 61 patients with locally advanced rectal cancer who underwent neoadjuvant CCRT followed by surgery between 2020 and 2024 were retrospectively analyzed. Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) parameters, including area, index, and mean attenuation (Hounsfield unit, HU), were measured at the L3 level on pre-treatment CT. Patients were classified into favorable (complete or near-complete response) and unfavorable response groups, as well as response and no-response groups. Statistical analyses included independent t-tests, chi-square tests, and receiver operating characteristic (ROC) curve analysis.

Results

In the favorable versus unfavorable response analysis, higher body mass index (BMI), larger VAT area, higher VAT index (VATI), and lower mean VAT attenuation were significantly associated with favorable response (all p < 0.05), whereas SAT-related parameters were not. In the response versus no-response analysis, SAT area and SAT index (SATI), but not mean SAT attenuation and VAT-related parameters, were significantly associated with treatment response (all p < 0.05). BMI was significantly associated with pathologic response only in the favorable versus unfavorable response group analysis, whereas no significant association was observed in the response versus no-response group analysis.

Conclusions

CT-derived adipose tissue parameters were differentially associated with pathologic response to neoadjuvant CCRT in locally advanced rectal cancer. VAT parameters, including both quantity and attenuation, were associated with favorable response, whereas SAT parameters were associated with overall treatment response, suggesting compartment-specific roles of adipose tissue in modulating treatment outcomes. While BMI demonstrated a significant association in one subgroup analysis, CT-based body composition analysis may provide more comprehensive and compartment-specific information beyond conventional anthropometric measures, and may serve as a potential imaging biomarker for predicting treatment response.

Schlagwörter

Stichwörter der Autor:innen

adipose tissueneoadjuvant concurrent chemoradiotherapyradiotherapyrectal cancertreatment response

Autor:innen und Institutionen

  • Department of Radiation Oncology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Department of Radiation Oncology, College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan 31151, Republic of Korea.
  • Department of Nuclear Medicine, College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan 31151, Republic of Korea.
  • Department of Surgery, College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan 31151, Republic of Korea.
  • Department of Pathology, College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan 31151, Republic of Korea.
  • Clinical Trial Center, Soonchunhyang University Cheonan Hospital, Cheonan 31151, Republic of Korea.

ORCID-Profile: Hye Jin Kang, Yong Kyun Won, Sang Mi Lee, Ik Dong Yoo, Jeong Won Lee, Si-Hyong Jang, Nam Hun Heo, Jae Won Kim, Taesung Ahn, In Young Jo

Förderung

  • Soonchunhyang University Hospital Cheonan
  • Soonchunhyang University Research Fund
  • Ministry of Science and ICT
  • National Research Foundation of Korea

Zitieren

APA

Kang, H. J., Won, Y. K., Kim, E. S., Lee, S. M., Yoo, I. D., Lee, J. W., Hong, S. P., Baek, M. J., Kang, D. H., Oh, M. H., Lee, J. H., Jang, S. H., Heo, N. H., Seo, J. A., Kim, J. W., Ahn, T., & Jo, I. Y. (2026). Differential Association of Visceral and Subcutaneous Adipose Tissue with Treatment Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Diagnostics, 16(11), 1624. https://doi.org/10.3390/diagnostics16111624

Vancouver

Kang HJ, Won YK, Kim ES, Lee SM, Yoo ID, Lee JW, et al. Differential Association of Visceral and Subcutaneous Adipose Tissue with Treatment Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Diagnostics. 2026;16(11):1624. doi:10.3390/diagnostics16111624

BibTeX
@article{Kang2026,
  author = {Kang, Hye Jin and Won, Yong Kyun and Kim, Eun Seog and Lee, Sang Mi and Yoo, Ik Dong and Lee, Jeong Won and Hong, Sun-Pyo and Baek, Moo-Jun and Kang, Dong Hyun and Oh, Mee-Hye and Lee, Ji-Hye and Jang, Si-Hyong and Heo, Nam Hun and Seo, Ji An and Kim, Jae Won and Ahn, Taesung and Jo, In Young},
  title = {Differential Association of Visceral and Subcutaneous Adipose Tissue with Treatment Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {1624},
  doi = {10.3390/diagnostics16111624}
}
Kostenlos starten →